Europe Articles

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Gazprom And EU To Maintain Strong Ties

Russian oil and gas producer Gazprom and European officials have confirmed that they are interested in maintaining the mutually beneficial business relationship they have developed after decades of...

Read article ›

Pages